KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today Invesco CurrencyShares Japanese Yen Trust FXY Safe Haven Performance Lags Gold Amid Macro and Geopolitical Volatility Fox Corporation FOX Upgraded to Zacks Buy Rating on Earnings Estimate Momentum What Gelteq Limited GELS is doing that smarter investors notice Institutional Selling 20260505 How Moderna MRNA responds to market challenges Risk Aversion 20260505 What PIMCO PAXS customer metrics tell us about future growth POLE Andretti management details upcoming SPAC merger plans in its latest quarterly earnings release How Sachem SCCG is positioning for the next five years Weakens 20260505